Research and Development

Atoxin aims to clone the genes of therapeutic value followed by small scale production of the derived proteins. These proteins will then be subjected to functionality tests. After confirming the desired functions, the proteins could be commercialized in the USA or other countries. The company also aims to produce PCR-based diagnostic kits for detecting cancers, bacteria and viruses.